Fearing abuse, FDA blocks generic OxyContin

WASHINGTON (AP) — Federal health regulators will require generic versions of the best-selling painkiller OxyContin to include recent formulation changes designed to make the pill harder to abuse.

The Food and Drug Administration said it would not approve any generic versions of OxyContin based on the original formulation because it “poses an increased potential for certain types of abuse.”

The FDA decision is a key victory for Purdue Pharma LP, which has spent years developing a tamper-resistant version of the blockbuster pain pill. The company’s patent on original OxyContin expires Tuesday and would normally open the door to a slew of cheaper generic versions.

However, the FDA decision effectively protects Purdue from lower-price competition by requiring generic manufacturers to develop their own abuse-deterrent designs.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s